Page last updated: 2024-09-05

sb 203580 and Adult Premature Aging Syndrome

sb 203580 has been researched along with Adult Premature Aging Syndrome in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (71.43)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bagley, MC; Davis, T; Dix, MC; Kipling, D; Rokicki, MJ1
Bachler, MA; Bagley, MC; Davis, T; Dix, MC; Kipling, D; Murziani, PG; Rokicki, MJ; Widdowson, CS; Zayed, JM1
Bachler, MA; Bagley, MC; Davis, T; Kipling, D; Wyllie, FS1
Brook, AJ; Davis, T; Kipling, D; Rokicki, MJ; Tivey, HS1
Baird, DM; Davis, T; Haughton, MF; Jones, CJ; Kipling, D1
Davis, T; Haughton, MF; Jones, CJ; Kipling, D1
Davis, T; Kipling, D1

Reviews

2 review(s) available for sb 203580 and Adult Premature Aging Syndrome

ArticleYear
Evaluating the role of p38 MAP kinase in growth of Werner syndrome fibroblasts.
    Annals of the New York Academy of Sciences, 2010, Volume: 1197

    Topics: Aging; Aging, Premature; Cell Cycle; Cell Proliferation; Cellular Senescence; Enzyme Inhibitors; Fibroblasts; Growth; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Werner Syndrome

2010
Prevention of accelerated cell aging in the Werner syndrome.
    Annals of the New York Academy of Sciences, 2006, Volume: 1067

    Topics: Actins; Aging, Premature; Cells, Cultured; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Enzyme Inhibitors; Fibroblasts; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Pyridines; Telomerase; Telomere; Tumor Suppressor Protein p53; Werner Syndrome

2006

Other Studies

5 other study(ies) available for sb 203580 and Adult Premature Aging Syndrome

ArticleYear
Rapid synthesis of VX-745: p38 MAP kinase inhibition in Werner syndrome cells.
    Bioorganic & medicinal chemistry letters, 2007, Sep-15, Volume: 17, Issue:18

    Topics: Blotting, Western; Enzyme-Linked Immunosorbent Assay; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridazines; Pyrimidines; Werner Syndrome

2007
Synthesis and in vivo activity of MK2 and MK2 substrate-selective p38alpha(MAPK) inhibitors in Werner syndrome cells.
    Bioorganic & medicinal chemistry letters, 2007, Dec-15, Volume: 17, Issue:24

    Topics: Cell Line; Humans; Intracellular Signaling Peptides and Proteins; Mitogen-Activated Protein Kinase 14; Molecular Structure; Phosphorylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Substrate Specificity; Werner Syndrome

2007
p38 (MAPK) stress signalling in replicative senescence in fibroblasts from progeroid and genomic instability syndromes.
    Biogerontology, 2013, Volume: 14, Issue:1

    Topics: Ataxia Telangiectasia; Cells, Cultured; Cellular Senescence; Fibroblasts; Genomic Instability; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Progeria; Protein Kinase Inhibitors; Pyridines; Stress, Physiological; Syndrome; Telomerase; Werner Syndrome

2013
Prevention of accelerated cell aging in Werner syndrome using a p38 mitogen-activated protein kinase inhibitor.
    The journals of gerontology. Series A, Biological sciences and medical sciences, 2005, Volume: 60, Issue:11

    Topics: Actins; Cell Cycle; Cells, Cultured; Cellular Senescence; Enzyme Inhibitors; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Pyridines; Telomere; Werner Syndrome

2005
Werner Syndrome as an example of inflamm-aging: possible therapeutic opportunities for a progeroid syndrome?
    Rejuvenation research, 2006,Fall, Volume: 9, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cellular Senescence; DNA Helicases; Exodeoxyribonucleases; Fibroblasts; Humans; Imidazoles; Inflammation; Intercellular Adhesion Molecule-1; Mutation; p38 Mitogen-Activated Protein Kinases; Pyridines; RecQ Helicases; Signal Transduction; Werner Syndrome; Werner Syndrome Helicase

2006